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Abstract
Extrinsic apoptosis is a programmed cell death triggered by external ligands, such as the TNF-related apoptosis inducing
ligand (TRAIL). Depending on the cell line, the specific molecular mechanisms leading to cell death may significantly differ.
Precise characterization of these differences is crucial for understanding and exploiting extrinsic apoptosis. Cells show
distinct behaviors on several aspects of apoptosis, including (i) the relative order of caspases activation, (ii) the necessity of
mitochondria outer membrane permeabilization (MOMP) for effector caspase activation, and (iii) the survival of cell lines
overexpressing Bcl2. These differences are attributed to the activation of one of two pathways, leading to classification of
cell lines into two groups: type I and type II. In this work we challenge this type I/type II cell line classification. We encode
the three aforementioned distinguishing behaviors in a formal language, called signal temporal logic (STL), and use it to
extensively test the validity of a previously-proposed model of TRAIL-induced apoptosis with respect to experimental
observations made on different cell lines. After having solved a few inconsistencies using STL-guided parameter search, we
show that these three criteria do not define consistent cell line classifications in type I or type II, and suggest mutants that
are predicted to exhibit ambivalent behaviors. In particular, this finding sheds light on the role of a feedback loop between
caspases, and reconciliates two apparently-conflicting views regarding the importance of either upstream or downstream
processes for cell-type determination. More generally, our work suggests that these three distinguishing behaviors should
be merely considered as type I/II features rather than cell-type defining criteria. On the methodological side, this work
illustrates the biological relevance of STL-diagrams, STL population data, and STL-guided parameter search implemented in
the tool Breach. Such tools are well-adapted to the ever-increasing availability of heterogeneous knowledge on complex
signal transduction pathways.
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Introduction
Apoptosis, a major form of programmed cell death, plays a
crucial role in shaping organs during development and controls
homeostasis and tissue integrity throughout life [1,2]. Moreover
defective apoptosis is often involved in cancer development and
progression [3]. Apoptosis can be triggered by intrinsic or extrinsic
stimuli. Intrinsic apoptosis is triggered in case of cell damage (e.g.
stress, UV radiation) or cell malfunction (e.g. oncogene activation).
Extrinsic apoptosis is initiated by the presence of extracellular
death ligands, such as Fas ligand (FasL), Tumor Necrosis Factor
(TNF), or TRAIL [2]. Because the latter has a unique ability to
trigger apoptosis in various cancer cell lines without significant
toxicity toward normal cells, TRAIL-induced apoptosis has been
the focus of extensive studies [1].
The effects of TRAIL application can be significantly different
from one cell line to another [4–6]. The current understanding is
that cell death results from the activation of one of two parallel
pathways, leading to the classification of cell lines into two distinct
cell types. In type I cells, effector caspases are directly activated by
initiator caspases. Mitochondria outer membrane permeabiliza-
tion (MOMP) is not required to generate lethal levels of caspase
activity. In type II cells, the activation of initiator caspases triggers
MOMP that in turn triggers effector caspases activation. MOMP
is required for cell death. This necessity of mitochondrial pathway
activation to undergo apoptosis is often referred as type II phenotype,
in contrast to type I phenotype where MOMP is a side effect of
apoptosis.
Many models of apoptosis, based on different mathematical
formalisms, ranging from logical models to differential equation
systems, have been proposed so far [2,6–21]. To investigate the
molecular origins of the two above-mentioned distinct phenotypes,
Aldridge and colleagues developed a model describing key
biochemical steps in TRAIL-induced apoptosis: extrinsic apoptosis
reaction model (EARM1.4) [6]. EARM1.4 is an extension of a
model developed to capture cell-to-cell variability in apopotosis of
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HeLa cells [15,16]. In [6], the authors tested the hypothesis that
the distinct cell behaviors can be explained solely by measured
differences in protein concentrations before stimulation among
different cell lines. Cell line models share the same set of ordinary
differential equations and kinetic parameters, but possess specific
protein contents at the initial state (i.e. before TRAIL application).
These differences in the initial concentrations of a dozen of key
apoptotic proteins are consistent with quantitative immunoblotting
measurements. Then the authors use an abstract criterion that
measures the influence of changes in initial protein concentrations
on the future states of the system (i.e. divergence of trajectories):
the direct finite-time Lyapunov exponent (DLE). They show that
this criterion defines a partition of the state space that preserves
known differences between phenotypes: type I and type II cells are
associated to distinct regions in the state space [6]. The DLE-
induced partition can be graphically represented as 2D slices of the
high dimensional state space called DLE diagrams [6,22]. As
shown in [6], DLE diagrams are intuitive tools to predict the effect
of mutations on cell type. However, the connection between the
abstract DLE notion and cell phenotypes remains elusive: why
type I and type II cells correspond to two different regions
separated by a third one having high DLE values? Understanding
this relationship is important to evaluate the general applicability
of the proposed approach. Moreover in [6], the authors also
probed the functioning of the apoptotic pathways in different cell
lines and for different mutants using three different experimental
methods: clonogenic assays, microscopy imaging and flow
cytometry measurements of immunostained cells. These experi-
ments probe subtly different aspects of the interplay of different
pathway components, and most notably on the role of MOMP in
the apoptotic response: death/survival following TRAIL stimula-
tion of derived cell lines overexpressing Bcl2 (Property 1),
synchronous/sequential activation of initiator and effector cas-
pases (Property 2), and effector caspase activation prior/posterior
to MOMP (Property 3). However, the authors do not test the
consistency of EARM predictions with the detailed experimental
information they provide.
In this work we address the two above-mentioned problems by
using a formal language, signal temporal logic (STL). STL was
originally developed for monitoring purposes to specify the
expected behavior of physical systems, including notably the order
of physical events as well as the temporal distance between them
[23]. Like other temporal logics and formal verification frame-
works [24–31], it has been applied to the analysis of biomolecular
networks [32,33]. In particular, because it allows expressing in a
rigorous manner transient behaviors of dynamical systems, one
can encode as STL properties various cellular responses observed
with different experimental methods and associated to type I/II
phenotypes. Because STL properties have a quantitative interpre-
tation, describing how robustly behaviors of the system satisfy or
violate the property, STL diagrams can be constructed analo-
gously to DLE diagrams. However, since STL diagrams are each
associated to a specific STL property their interpretations do not
suffer from ambiguities. Moreover, one can benefit from the
expressive power of the STL language to encode detailed
experimental information and thoroughly test the consistency of
EARM with the various observations (Figure 1).
We report three findings. Firstly, our results highlighted that the
three experimental methods proposed in [6] to investigate the
importance of MOMP for cell death from three different
perspectives, each suggesting a type I/II distinguishing criterion,
do not lead to consistent cell line classifications. For example the
DXIAP HCT116 cell line should be classified as type II based on
Properties 1 and 2, and as type I based on Property 3. This
challenges the well-posedness of the type I/II notion. Secondly,
using our systematic approach, we found several inconsistencies
between model predictions and actual observations. Taking again
advantage of the quantitative interpretation of STL properties, we
searched for valid parameters using a cost function that is minimal
when all properties are consistent with experimental data and
state-of-the-art global optimization tools. Inconsistencies have
been resolved simply by modifying a few parameters, thus showing
that there is no need for structural changes in the model. Thirdly,
our findings reconciliate the apparently contradictory views
expressed by Scaffidi and colleagues [5] and Aldridge and
colleagues [6] about the origins of type I and II phenotypes.
Indeed, Scaffidi, Barnhart and colleagues suggest that the initiator
caspase activation capabilities are the main determinants of the
type I/II phenotype of a cell line [5,34], whereas Eissing and
colleagues, Jost and colleagues, and Aldridge and colleagues
suggest that the latter is mainly controlled by the relative
abundance of downstream proteins, most notably XIAP and
caspase-3 [4,6,7]. Our results suggest that, unlike downstream
proteins, the modification of the concentration of upstream
proteins within physiological range has a negligible effect on
cellular responses. However, the critical effects of downstream
protein concentration changes are fed back to upstream processes
and are amplified via a positive feedback loop involving caspases 3,
6, and 8, leading to the activation of initiator caspases. Finally, the
comparison of the STL and DLE diagrams showed that the DLE
criterion essentially captures the notion of cell survival or cell
death, like Property 1. This lead us to better understand why the
fairly abstract DLE criterion induced biologically-relevant parti-
tions in the work of Aldridge and colleagues [6]. A last
contribution is that we extended the functionalities of the Breach
tool [33] so that phase diagrams can be automatically computed
given any differential equation model and STL property.
Therefore, the methodology presented here can be applied to
other complex biomolecular networks.
The first three sections of the Results part deal with the detailed
analysis of three different observed phenotypes associated with
Author Summary
Apoptosis, a major form of programmed cell death, plays a
crucial role in shaping organs during development and
controls homeostasis and tissue integrity throughout life.
Defective apoptosis is often involved in cancer develop-
ment and progression. Current understanding of externally
triggered apoptosis is that death results from the
activation of one out of two parallel signal transduction
pathways. This leads to a classification of cell lines in two
main types: type I and II. In the context of chemotherapy,
understanding the cell-line-specific molecular mechanisms
of apoptosis is important since this could guide drug
usage. Biologists investigate the details of signal transduc-
tion pathways often at the single cell level and construct
models to assess their current understanding. However, no
systematic approach is employed to check the consistency
of model predictions and experimental observations on
various cell lines. Here we propose to use a formal
specification language to encode the observed properties
and a systematic approach to test whether model
predictions are consistent with expected properties. Such
property-guided model development and model revision
approaches should guarantee an optimal use of the often
heterogeneous experimental data.
STL-based Analysis of TRAIL-induced Apoptosis
PLOS Computational Biology | www.ploscompbiol.org 2 May 2013 | Volume 9 | Issue 5 | e1003056
type I/II behaviors, encoded in STL, and confronted with model
predictions. In the last two sections, we study whether the EARM
model can be reconciled with all the considered observations on all
cell lines and search for the origins of cell type differences.
Results
Property 1: Type II cells survive if Bcl2 is over-expressed
STL encoding. Bcl2 over-expression is the standard experi-
mental method for distinguishing type I and type II cells [5]. Type
I cells overexpressing the anti-apoptotic protein Bcl2 die in the
presence of death ligand but type II cells survive. The
sequestration of Bax by high levels of Bcl2 prevents the formation
of pores in the mitochondrial outer membrane (Figure 2).
Therefore clonogenic survival of an OE-Bcl2 derived cell line
reveals the need for MOMP to trigger cell death in type II cells.
Clonogenic survival data is available in [6] for three cell lines,
SKW6.4 (human B lymphoma cells), HCT116 (human colon
carcinoma cells), T47D (human breast carcinoma cells), and for
the DXIAP mutant of HCT116 cells [6,35,36]. Cells were exposed
to a 50 ng/ml TRAIL treatment for 6 hours.
Here, we encode in STL the observations made in clonogenic
assays on HCT116, SKW6, and T47D cells [6]. Effector caspases
cleave essential structural proteins and inhibitors of DNase,
leading eventually to cell death. PARP is a substrate of these
effector caspases and its cleavage is often regarded as a marker of
commitment to death by cells [15,16,37]. Therefore, we consider
here that a cell is alive if less than a half of the PARP proteins is
cleaved. In STL, this translates into: alive: = cPARP/PARPtotal,0.5.
Note that although the 50% threshold used here is somewhat
arbitrary, we found that our conclusions are robust with respect to
threshold changes in the range 10%–90% (see Figure S1). Then
cell survival is simply expressed in STL as the cell is always alive:
Property1: = always[0–6h](alive). Here, always is an STL keyword (see
Methods). Its scope is limited to the first 6 hours as in experiments.
STL phase diagrams. For each initial protein concentration,
one can predict the behavior of the system after TRAIL
stimulation and assess whether this behavior satisfies a given
STL property, or more precisely, estimate the value of the STL
property given the behavior (see Methods). One can then
graphically represent the value of the property in the state space
by so-called phase diagrams (see Methods). The placement of cell
lines in the phase diagram, based on their initial protein
concentrations, indicates whether the cell line satisfies the given
property (see Methods). Since it has been shown that the ratio of
XIAP to caspase-3 concentrations plays a key role for the
determination of the apoptotic type [6], we first constructed
diagrams associated with these two variables. The corresponding
STL phase diagram associated to Property 1 is represented in
Figure 3. The death/survival property is tested in derived cell lines
where Bcl2 is overexpressed (OE-Bcl2 cells; 10-fold increase of
Bcl2 initial concentrations). The presence of two distinct regions in
Figure 1. Property-based model analysis framework. Heterogeneous observations on the system are formalized as STL properties. Consistency
between model and experimental observations is tested via STL diagrams and population data. Inconsistencies can be resolved via property-guided
model revision. In contrast to DLE, STL properties explicitly encode specific aspects of cell’s response, in our case, of the role of mitochondria in type I/
II apoptosis. Bold boxes allows distinguishing our contribution with respect to the work of Aldridge and colleagues [6]. (Images reused with
permission from Nature Publishing Group).
doi:10.1371/journal.pcbi.1003056.g001
STL-based Analysis of TRAIL-induced Apoptosis
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the diagram, one where Property 1 is satisfied (positive values,
green) corresponding to cell survival, typical of type II cells, and
one where Property 1 is falsified (negative values, red) correspond-
ing to cell death, typical of type I cells, suggests that the model
correctly predicts the importance of the XIAP/caspase-3 ratio as a
key factor to determine cell survival following TRAIL treatment.
We then positioned cell lines in the diagram based on measured
mean and standard deviations of protein concentrations (see
Methods). In agreement with the observations (Figure 2B in [6])
and the known type of these cell lines, the STL diagram predicts
that OE-Bcl2 HCT116 cells do satisfy Property 1, but OE-Bcl2
SKW6.4 cells do not. OE-Bcl2 T47D cells are located close to
separatrix and most cells satisfy Property 1. This is only in partial
agreement with the fact that only half of T47D cells were found to
survive (Figure 7C in [6]). Interestingly, as noted by Aldridge and
colleagues, one can immediately see the consequences of
mutations [6]. For example, DXIAP cell lines are shifted to the
leftmost part of the diagram (regions with low XIAP concentra-
tions) and are thus predicted to violate Property 1. That is, all OE-
Bcl2/DXIAP mutants of the HCT116, SKW6.4, and T47D cell
lines are predicted to die in clonogenic experiments. This is again
in accordance with experimental observations for HCT116 cells
(Figure 2B in [6]). A detailed comparison of the Property 1
diagrams and the DLE diagrams used in [6] shows that the
successful classification of cells provided by DLE diagrams
implicitly relies on the snap-action, all-or-none aspect of apoptosis
(Figure S2). Using the approach we propose here, the property of
interest is explicitly stated and the interpretation of the resulting
diagrams is not ambiguous. Moreover, since STL is a property
specification language, this framework can be applied to analyze
other properties of the system, not necessarily relying on snap-
action responses.
STL population data. Using STL diagrams helps in
understanding how cell behavior depends on its initial protein
content and hence suggests why cell lines exhibit different
phenotypes. However, DLE and STL diagrams suffer from some
limitations. In both cases, only two initial protein concentrations
are modified (XIAP and caspase-3 in our examples). Therefore,
they fail to capture all the differences between cell lines. In more
precise terms, DLE and STL diagrams represent the value of the
DLE or of an STL property in a 2D slice of the high-dimensional
state space, and cell line distributions are projected onto the slice.
Therefore, even if they provide insight into the behavior of cells
that are affected by changes in initial protein concentrations, DLE
and STL diagrams must be interpreted with care. The information
is exact for the cell line used to construct the diagram, called the
Figure 2. Simplified view on TRAIL-dependent apoptotic pathway. The activation of the membrane receptor by TRAIL binding promotes the
assembly of the death-inducing signaling complexes (DISC), which recruit and activate initiator (pro-) caspases, including notably caspase-8 (C8) [53].
The recruitment of initiator caspases is modulated by FLIP. Once activated, initiator caspases cleave and activate effector caspases such as caspase-3
(C3). This effect is reinforced by a feedback loop involving caspase-6 (C6). Effector caspases cleave essential structural proteins, inhibitors of DNase,
and DNA repair proteins (PARP), eventually leading to cell death. The cellular effect of effector caspase activation is regulated by factors such as the X-
linked inhibitor of apoptosis protein (XIAP), which blocks the proteolytic activity of caspase-3 by binding tightly to its active site [54] and promotes its
degradation via ubiquitination [55]. In addition to the direct activation of effector caspases, initiator caspases also activate Bid and Bax [56]. If not kept
in check by inhibitors, most notably Bcl2, activated Bax directly contributes to the formation of pores in the mitochondria outer membrane, leading
to MOMP [57]. Following MOMP, critical apoptosis regulators, such as Smac and cytochrome c (CyC), translocate into the cytoplasm. Smac binds to
and inactivates XIAP, thus relieving the inhibition of effector caspases by XIAP [58]. Cytochrome c combines with Apaf-1 to form the apoptosome that
in turn activates the initiator caspase-9 that activates effector caspases.
doi:10.1371/journal.pcbi.1003056.g002
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reference cell line, but it is only approximate for other, projected
cell lines. To investigate how the diagrams change when reference
cell line change, we constructed the Property 1 diagrams with
respect to OE-Bcl2 HCT116, OE-Bcl2 SKW6.4, and OE-Bcl2
T47D cell lines (Figure S3A–C). Although the conclusions based
on Figure 3 are indeed valid for HCT116 and SKW6.4 cell lines
(OE-Bcl2 HCT116 cells survive, OE-Bcl2 SKW6.4 cells die), they
differ for T47D cells. When using a slice of the state space based
on OE-Bcl2 T47D cells, it appears that these cells are classified as
exhibiting mixed-type behaviors (Figure S3C), as experimentally
observed, instead of mostly type I as suggested by Figure 3. This
example illustrates that problems may arise when placing different
cell lines on the same phase diagram. To obtain a less
comprehensive but more accurate view of the value of STL
properties, we propose to use STL population data in combination
with phase diagrams. Population data are statistics describing the
STL property values associated to whole cell populations (see
Methods). For Property 1, these statistics are presented in Figure 4
(and Figure S4 for all cell lines). One can first check that indeed
the mean values, distributions and satisfaction rates of Property 1
are qualitatively consistent with the predictions we obtained from
the STL diagram in Figure 3 for the OE-Bcl2 HCT116, OE-Bcl2
SKW6.4, OE-Bcl2 T47D, and OE-Bcl2/DXIAP HCT116 cells.
Moreover, the satisfaction rates in Figure 4 can be directly
compared with the experimentally-measured survival rates in
clonogenic assays (Figure 2B and Figure 7C in [6]). Strikingly, our
data shows excellent quantitative agreement with observed cell
behaviors for all but the parental T47D cell line. Like in
clonogenic assays, we predict the survival of a large majority of
OE-Bcl2 HCT116 cells, half of the OE-Bcl2 T47D cells and a
minority of HCT116 cells, the death of all DXIAP HCT116 and
SKW6.4 cells and their OE-Bcl2 variants. The sole discrepancy
concern T47D cells that are predicted to be more resistant to
apoptosis than experimentally-observed.
Property 2: Activations of initiator and effector caspases
are sequential in Type II cells
STL encoding. In addition to survival of derived cell lines
overexpressing Bcl2, Scaffidi and colleagues observed another
important difference between type I and II cell lines: the dynamics
of the activations of initiator and effector caspases by cleavage
shows marked differences [5]. These are two critical events that
can be considered as markers of the beginning and of the end of
the apoptosis decision-making process. By using Western blots,
Scaffidi and colleagues showed that in type I cells the activation of
the effector caspase caspase-3 closely follows the activation of the
initiator caspase caspase-8: caspase activations are gradual and
near synchronous. In contrast, in type II cells the activation of
initiator caspases is not closely followed by the activation of
effector caspases [5]. Similar results have been obtained with a
cellular resolution using FACS analysis (Figure 5 in [6]). The
current understanding is that effector caspase activation is delayed
until MOMP happens. Hence, the observed sequential activation
is explained by a pre-MOMP delay in type II cells. Therefore this
synchronous versus sequential activation is not only a robustly
observed pattern but also relates to mechanistic interpretation of
cell death.
We will consider that initiator and effector caspases activations
are sequential if they are separated by more than one hour, in
accordance with the low-temporal resolution of available obser-
vations in [5,6]. So to express sequential activation, we say that ‘‘at
some time point, caspase-8 is active and for at least an hour,
caspase-3 remains inactive’’. Hence, we have the following STL
formula: Property2: = eventually(Casp8active and always[0–1h] not Casp3active).
We still have to set the threshold concentration for cleaved
caspases that corresponds to a detectable activity. Since it has
been shown that caspases are highly potent proteases (a few
hundred caspases can cleave millions of substrate proteins within
hours [38,39]), we set this threshold concentration to 1% of the
total caspase concentration: Casp8active: = Casp8*/Casp8total.1%,
and Casp3active: = Casp3*/Casp3total.1% where Casp8* and Casp3*
are the sum of the concentrations of all cleaved forms of
caspase-8 and caspase-3, with the exclusion of caspase-8 bound
to Bar and of caspase-3 bound to XIAP, respectively (the
influence of the threshold is discussed in Figure S1).
STL phase diagrams and population data. Having
formalized our property in STL, one can automatically construct
the corresponding diagram (Figure 5, left). On this diagram one
can clearly see two distinct, positive and negative, regions.
HCT116 and T47D cells lie in the positive region and hence
are predicted to satisfy Property 2, whereas SKW6.4 cells lie on
the separatrix, and hence are predicted to show a mixed
phenotype with respect to Property 2. Note that in the case of
SKW6.4 cells, it is important to consider the diagram computed
with respect to this cell line to have an accurate representation
(compare S3D and E). The diagram also predicts that DXIAP
mutants violate Property 2 (i.e. lie in the negative region). The
predicted phenotypes of HCT116 and of DXIAP HCT116 cells
are consistent with observations: whereas HCT116 cells show a
clear sequential activation of caspases, this behavior is lost in
DXIAP HCT116 cells [6]. Diagram shows that EARM1.4 is also
compatible with the hypothesis that high levels of XIAP control
caspase activation and substrate cleavage, and may promote
apoptosis resistance and sublethal caspase activation in vivo [13].
However, the predicted phenotype of SKW6.4 cells is in
contradiction with the observed one (Figure S3E and Figure 5
Figure 3. Property-1 phase diagram. Each point in the diagram
represents a different initial concentration for XIAP and caspase-3
proteins, and its color represents the value of Property 1 evaluated on
cell simulated behavior starting in these initial conditions (p1: =
always[0–6h](cPARP/PARPtotal,0.5)). Other protein concentrations corre-
spond to nominal protein concentrations for HCT116 cells (Table 1).
Green regions satisfy the property (positive values). Red regions do not
(negative values). Cell lines can be positioned in this diagram, using
crosses which center and size are determined by the mean and
standard deviation of measured protein concentrations (Methods and
[6]).
doi:10.1371/journal.pcbi.1003056.g003
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Right). As expected from type I cells, SKW6.4 cells clearly show
synchronous activations of caspases and shoud therefore violate
Property 2. The analysis of the OE-Bcl2 mutants of the HCT116,
DXIAP HCT116, and SKW6.4 cell lines shows that consistent
results are obtained in these cases (Figure 5, right). One should
note that because caspase-3 is not activated in OE-Bcl2 HCT116
cells (they survive TRAIL treatment), Property 2 holds trivially in
these cells. To investigate whether EARM1.4 can account for the
observed phenotype of SKW6.4 cells, we slightly relaxed the
timing constraint between the caspases activation times and found
that by setting a slightly longer delay (e.g. 1h30 min), the mean
value of Property 2 for the SKW6.4 cell population becomes
negative as expected, and even more, that the percentage of cells
satisfying Property 2 decreases to zero with longer delays.
Therefore we conclude that the observed discrepancy results from
EARM 1.4 limitations to capture quantitatively the elapse of time
between events, rather than from severe modeling flaws.
Property 3: MOMP precedes caspase-3 activation in Type
II cells
STL encoding. In type I and type II cells, MOMP happens
during apoptosis with comparable kinetics [5]. This is in apparent
contradiction with the very different role of MOMP in the two
Figure 4. Property 1 population statistics. Plots indicate the satisfaction of Property 1 by the nominal cell (cross, top), the distribution of the
values (middle), and the percentage of satisfaction (bottom) of Property 1 for populations of cells of different cell lines. For distributions, box
boundaries and red line indicate first and third quartiles, and median, respectively. When experimental data is available, circles in the top plot
represent the expected values. The following abbreviations are used in this and further figures: H is HCT116, HX is DXIAP HCT116, HB is OE-Bcl2
HCT116, HBX is OE-Bcl2/DXIAP HCT116, S is SKW6.4, SX is DXIAP SKW6.4, SB is OE-Bcl2 SKW6.4, SBX is OE-Bcl2/DXIAP SKW6.4, T is T47D, TX is DXIAP
T47D, TB is OE-Bcl2 T47D and TBX is OE-Bcl2/DXIAP T47D.
doi:10.1371/journal.pcbi.1003056.g004
Figure 5. Property-2 phase diagram and statistics. Left: Values of Property 2 evaluated on cell simulated behaviors and represented as a
function of the XIAP and caspase-3 initial concentrations (p2: = eventually(Casp8active and always[0–1h] not Casp3active)). Other protein concentrations
correspond to nominal protein concentrations for HCT116 cells. As in Figure 3, cell lines are positioned in this diagram according to their protein
initial concentrations. Right: distributions of the values of Property 2 across populations of cells of different cell lines. Notations are identical to those
used in Figure 4. Note the discrepancy between the predicted (cross) and expected (circle) values for Property 2 in SKW6.4 cells.
doi:10.1371/journal.pcbi.1003056.g005
STL-based Analysis of TRAIL-induced Apoptosis
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pathways, as revealed by Bcl2 overexpression experiments
(Property 1), and with the different kinetics of caspases activations
(Property 2). The current understanding is that in type I cells
MOMP is a consequence of effector caspases activation, whereas
in type II cells, MOMP is the cause of effector caspases activation
[5,34,40]. Under this assumption one should observe that in the
first case MOMP follows effector caspases activation, and in the
second case, that MOMP precedes effector caspases activation.
This question has been directly investigated by Aldridge and
colleagues by staining cells with anti-cytochrome c and anti-
cPARP antibodies [6]. The authors demonstrate that most of
HCT116 cells showing effector caspases activation also show
cytoplasmic cytochrome c localization indicating that MOMP has
happened. Stated differently, caspase-3 is not active until MOMP
happens. This is not always true for DXIAP HCT116 cells, or for
OE-Bcl2 DXIAP HCT116 cells: a significant proportion (respec-
tively 20% and 80% of the cells) shows effector caspase activation
in absence of cytoplasmic cytochrome c (Figure 3 in [6]). The same
experiment was made for T47D and OE-Bcl2 T47D cells,
showing that these cells behave like HCT116 cells: caspase-3 is
not active until MOMP happens (Figure 7 in [6]).
To test the consistency of EARM1.4 with these observations, we
express in STL the property, typical of type II behaviors, that cells
remain alive until MOMP happens. We simply write Proper-
ty3: =MOMP release alive. The release operator states that the second
property (alive) must hold until the first property holds for the first
time (MOMP). The occurrence of MOMP is detected by the
titration of Apaf-1 by the released cytochrome c to form the
apoptosome. We say that MOMP happened when more than 50%
of Apaf-1 is bound to cytochrome c: MOMP: =Apaffree/Apaftotal,0.5
(see Figure S1 for discussion of threshold).
STL phase diagrams and population data. We used
Breach to compute the STL diagram associated with Property 3
with respect to HCT116 cells, and the Property 3 population data
(Figure 6). One should note that like in the in vitro setup of [6], only
cells in which MOMP happened were taken into account: we
excluded surviving cells to compute statistics.
The diagram presented in Figure 6 is consistent with the
observation that HCT116 cells satisfy the property. However, it
suggests that the DXIAP mutant falsify the property, since
negative values are found in the region where XIAP concentra-
tion is null. This is in contradiction with the observation that
caspase-3 is active before MOMP happened in a majority (80%)
of these cells. In summary, DXIAP HCT116 cells present a type I
phenotype with respect to clonogenic survival and caspases
activation dynamics, and a type II phenotype with respect to the
need for MOMP for cell death, but the model classifies them as
type I cells for all properties. In fact, the fact that DXIAP
HCT116 cells have been observed to satisfy Property 3 but not
Property 2 imposes strong constraints on the kinetics of the
apoptosis process. In these cells, caspase-3 activation is preco-
cious, since it follows by less than one hour the activation of
caspase-8, implying that death (i.e. PARP cleavage) is rapid since
it follows shortly after caspase-3 activation. But then Property 3
implies that MOMP happened even before this time instant.
Given the efficient caspase-3 activation in EARM1.4, the model
fails to capture the need for MOMP in these cells. Lastly, one can
note that contradictions are also found with T47D, and OE-Bcl2
T47D cells (Figure 6, right).
Improving EARM 1.4: Property-guided parameter search
In summary, we found that EARM1.4 satisfies the majority of
the observed behaviors encoded in STL (Figure 7). This is
commendable for a model of this size and complexity, given that
EARM1.4 has not been tuned with respect to these properties,
even if the model and the specific observations we used to state our
STL properties have been published in the same paper [6].
However, few discrepancies were identified. It is important to test
whether the proposed model is structurally not capable of
accounting for all the observed properties. If not, this would call
for significant model revision.
We first tried to resolve inconsistencies by minor adjustments
of the thresholds we used in formulae. However, property
satisfaction values proved robust to threshold changes (Figure S1).
Figure 6. Property-3 phase diagram and statistics. The value of Property 3 (p3: =MOMP release alive) is represented as a function of the XIAP
and caspase-3 initial concentrations. Other protein concentrations correspond to nominal protein concentrations for HCT116 cells. As in Figure 3, cell
lines are positioned in this diagram according to their protein initial concentrations. Note that HCT116 cells depleted from all XIAP ([XIAP] = 0) are
predicted not to satisfy Property 3. This is in contradiction to experimental observations [6]. (Right) Distributions of the values of Property 3 across
populations of cells of different cell lines. Notations are identical to those used in Figure 4. One can note that discrepancies between predicted mean
values (crosses) and observed phenotypes (circles) exist for DXIAP HCT116, T47D and OE-Bcl2 T47D cells.
doi:10.1371/journal.pcbi.1003056.g006
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We therefore resorted to search for better parameter values
using global optimization methods [41]. We defined a cost
function that indicates for any given parameter how far the
model is from satisfying all its constraints. More precisely, the
cost function aggregates three measures: how many properties
are consistent with the observations, how robustly satisfied or
falsified they are, and how large are the deviations of the
parameters with respect to their reference values. Then, we used
the global optimization tool CMA-ES [42] to search automat-
ically for parameters minimizing this cost function (see
Methods). Here, one should note that the real-valued semantics
of STL properties is critical: continuous optimization tools take
advantage of the graded interpretation of STL properties, whose
values indicate their ‘‘distances from satisfaction’’. The sole use
of traditional Boolean-valued interpretations of temporal logic
formulae would have made this search impractical. Because of
their ambiguous phenotypes, T47D cell data were not used for
parameter search. We started with 43 parameters, that is, all
catalytic and forward reaction rates (see Method section). After
applying our optimization procedure we found that the
modification of only 2 parameters was sufficient to achieve full
agreement with experimental data. The parameters found by
the search procedure are a parameter regulating the strength of
the caspases feedback loop (2.71 fold increase) and a parameter
regulating the kinetics of PARP cleavage (55.6 fold decrease)
(Table S1). Given the usually large uncertainties in actual
parameter values, such changes can still be considered as
acceptable. New parameter values lead to satisfaction of
Property 1–3 in nominal cells corresponding to all HCT116
and SKW6.4 normal and derived cell lines. To test whether
property values are corrected at the cell population level, we
recomputed the population data with these new parameter
values. As shown in Figure S5, all inconsistencies were indeed
resolved at the cell population level for all cell types (again with
the exception of T47D cells).
Origins of type I/II behaviors: Key role of downstream
proteins and of a positive feedback loop
It is important to note that the significantly different phenotypic
responses of the different cell lines are in the model solely
explained by observed differences in the initial concentrations of a
dozen of key proteins. Therefore one can use EARM1.4 with new
parameter values (Table S1) and STL diagrams to investigate the
origins of the different behaviors shown by cell lines. One important
question is to distinguish whether the different behaviors can be
explained exclusively by differences in upstream protein concen-
trations or exclusively by differences in downstream protein
concentrations, or whether a combination of upstream and
downstream changes is needed [6]. Indeed, it has been proposed
that the main differences between type I and II behaviors are
essentially due to differences in the efficiency of initiator caspase
activation by the DISC [5,34,43]. It has also been proposed that
the main determinant is the concentration of XIAP relative to
caspase-3 [4,6]. These questions can easily be answered using STL
diagrams. Figure 8 shows the XIAP/caspase-3 and FLIP/caspase-
8 diagrams for Property 2, computed with respect to the HCT116
cell line. It is apparent that the sole change of the concentrations of
XIAP and capsase-3 from their original values to values
corresponding to SKW6.4 cells is sufficient to alter the behavior
of those cells from a type II to a type I phenotype. A similar
change but for FLIP and caspase-8 proteins has no effect: cells
remains with a type II phenotype. As illustrated in Figure S6 and
S7, this is true for all properties and both directions (i.e., modifying
protein concentrations from HCT116 to SKW6.4 values and vice-
versa). This lack of influence of any upstream protein concentra-
tion is in apparent contradiction with the markedly different
profiles for caspase-8 activation observed experimentally in [5]
between type I and type II cells, and in EARM1.4 between
HCT116 and SKW6.4 cell lines, and even more between normal
and DXIAP cells that differ only in XIAP concentration (Figure 8C
and 8D). The latter comparison suggests that differences in
downstream protein concentrations feed back on upstream protein
activities. To test this, we created feedback mutants (denoted DFB
cells) by zeroing the cleaveage rate of caspase-8 by caspase-6.
Similar activation profiles for caspase-8 in HCT116 and SKW6.4
cell lines were then obtained showing that in normal conditions
differential activation of upstream processes is the consequence of
differential downstream processes activation (Figure 8C and 8D).
So, one can reconciliate the different views expressed by Scaffidi
and colleagues and by Aldridge and colleagues [5,6]. There are
indeed functionally significant differences in upstream protein
activities (e.g. caspase-8) in type I and II cells. However, according
to EARM1.4 model, these differences do not result from
differences in upstream protein levels but rather from downstream
differences that feed their influence back on upstream processes.
The feedback loop is required to preserve synchronous initiator
and effector caspase activation in type I cells. Note that using STL
was instrumental here. Indeed, because all cells die in these
Figure 7. Summary of findings. Truth values of the three properties based on observations in [6] for the HCT116, SKW6.4, and T47D cell lines and
some mutants. N/A indicates that the experimental information is not available. Experiments showed that OE-Bcl2 T47D cells present clonogenic
survival rates close to 50%, hence their ‘‘mixed’’ behavior. Consistency or discrepancy with predictions from the original EARM 1.4 model obtained
using our approach are indicated by green or red marks. Because of their ambiguous phenotypes, T47D cell data (in grey) were not used for
parameter search.
doi:10.1371/journal.pcbi.1003056.g007
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simulations (no Bcl2 overexpression), DLE diagrams were not
offering relevant information.
Interestingly, the analysis of the FLIP/caspase-8 STL diagrams
for Property 2 and 3 reveals that moderate inhibition of caspase-8
levels (e.g., by one third) in SKW6.4 cells would transform them into
cells showing mixed type behaviors (Figure S7 D and F). Indeed the
model predicts that these cells would present a sequential activation
of caspases (Property 2 satisfied; a type II feature) and a MOMP-
independent death (Property 3 violated; a type I feature). This
mutant would show exactly the opposite behavior of DXIAP
HCT116 cells, a combination of behaviors that has not yet been
observed. Therefore, the detailed analysis of this cell line could
possibly provide valuable information on the interplay between the
two apoptotic pathways. Similarly, the partial inhibition of caspase-
3 levels in SKW6.4 cells would also lead to cells showing mixed type
behaviors (Property 1 remains false whereas Property 2 and 3
change to true; Figure S6 B, D, and F).
Discussion
In this work, we expressed in a formal language, STL, a number
of observed properties on molecular details of extrinsic apoptosis
in several mammalian cell lines, and systematically tested their
consistency with a previously-proposed model developed to
capture the same process in the same cell lines, EARM1.4. It is
important to note that even if model and experimental data have
been published in the same article [6], the model has not been
tuned to comply with the various observed properties we tested on
the different cell lines. Indeed, we found several inconsistencies
between model predictions and experimental observations. These
inconsistencies can be resolved by model reparametrization
involving a limited number of parameter changes. However, these
needed changes were affecting key processes, namely the PARP
cleavage rate and the strength of the caspases-3, -6 and -8 feedback
loop. It is remarkable that the model was able to explain a number
Figure 8. Investigating the role of upstream proteins. (A) XIAP/caspase-3 and (B) FLIP/caspase-8 Property 2 diagrams using HCT116 as
reference cell line. Changes in XIAP/caspase-3 levels in HCT116 cells to match levels found in SKW6.4 cells change the original type II phenotype into
a type I phenotype. This is not the case for FLIP/caspase-8 changes. (B) The corresponding DLE diagram does not offer intuitive interpretation. (C and
D) Temporal evolution of active caspase-8 (top) and cleaved PARP (bottom) in HCT116 cells (red circle), SKW6.4 cells (blue circle), DXIAP HCT116 cells
(red triangle), DXIAP SKW6.4 cells (blue triangle), DFB HCT116 (red star) and DFB SKW6.4 cells (blue star). The comparison of HCT116 and SKW6.4 cell
lines with their DXIAP mutant shows important differences in the caspase-8 activation profile. Downstream proteins change upstream protein
activation.
doi:10.1371/journal.pcbi.1003056.g008
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of experiments probing different aspect of apoptosis made on
different cell lines and mutants, simply by taking into account
observed differences in protein concentrations but keeping the
same model structure and reaction rates for all cell lines. This
makes it a valuable tool to investigate the origins of the two different
cell responses. Unlike in in vivo experiments, the number of factors
that could explain these differences is limited in EARM1.4. Using
STL diagrams, we showed that observed differences in the
concentrations of upstream proteins in different cell lines could not
account for the observed cell type changes. This finding is
consistent with the observation based on in vivo and in silico works
that downstream proteins, most notably XIAP and caspase-3, play
a key role [6], but is in apparent contradiction with the
observation that upstream protein activities are markedly different
in type I and II cell lines [5]. Detailed analysis showed that the
effects of downstream protein concentration differences are in fact
fed back to upstream processes and amplified via the positive
feedback loop involving caspases 3, 6, and 8. This finding
reconciliates the views expressed by Scaffidi and colleagues and by
Aldridge and colleagues [5,6].
Based on experimental observations, we defined three proper-
ties associated with type II behaviors: (1) the cell survives if Bcl2 is
over-expressed, (2) the activations of initiator and effector caspases
are sequential, and (3) MOMP precedes caspase-3 activation.
They all assess the role of mitochondria for cell death and differ
only in subtle means. However, they are not always equivalent.
For example, DXIAP HCT116 cells satisfy Property 3 but not
Property 2, leading to interpretations like DXIAP HCT116 being
type I cells while exhibiting a type II phenotype. Based on our
work, there is no evidence that one property could be considered
as a defining criterion, excepted maybe for historical or practical
reasons (cell types were originally defined based on caspase
activation kinetics whereas Bcl2 overexpression is considered as
the standard method for cell type classification). This challenges
the consensual understanding that there exists (implicitly) well-
defined type I and type II phenotypes. It should be noted that here
we go beyond the notion of mixed cell type introduced by Aldridge
and colleagues for describing T47D cells. The authors implicitly
assume that cell types are well defined but that within a population
of cells a mixture of both phenotypes can be observed, coming
from cell-to-cell variability [16,44,45]. Here we propose that these
three properties are considered as type II features. Then the DXIAP
HCT116 cells would be more consistently qualified as possessing
some type I and some type II features. With the accumulation of
more detailed characterizations of apoptosis in more cell lines, it is
likely that the use of the loosely-defined notion of cell types will
otherwise become more and more problematic.
Like the DLE diagrams introduced by Aldridge and Haller [22],
STL diagrams are a convenient and intuitive way to represent the
influence of various factors on complex dynamical properties.
However, STL diagrams are superior on several counts. Firstly,
one can benefit from the expressive power of temporal logics to
express different observed properties of the dynamics of the cell
response. It allows us to test in which respect are the cell lines
different. Secondly, although the evaluation of STL properties and
of the DLE returns continuous values, the fact that STL values are
signed – positive values indicate satisfaction and negative values
indicate falsity – allows for a more direct interpretation of the
diagrams. Moreover, it allows defining statistics over populations
of cells. Thirdly, DLE generates well-defined partitions if in some
regions a small change in the initial state has a mild effect on the
future system’s state, thus generating low DLE values, and in other
regions, similar changes have drastic effects, thus generating high
DLE values. Although this is clearly the case in cell lines
overexpressing Bcl2 since some cells die, whereas others survive
(Figure 3), this is not generally true.
DLE and STL diagrams are particularly useful to have a rapid
view of the consequences of changing a few factors, initial
concentrations in our case. This feature allows us to foresee the
consequences of mutations (e.g. DXIAP mutants in XIAP/
caspase-3 diagrams), to investigate the (lack of) influence of given
factors (e.g. FLIP changes in FLIP/caspase-8 diagrams), and to
assess the influence of cell-to-cell heterogeneity by representing
graphically the means and standard values of populations in
diagrams. However, heterogeneity in diagrams is limited to two
dimensions. Moreover, since the cell lines differ in more than two
dimensions, only one cell line can be correctly mapped in the state
space slice of the diagram. Other cell lines are projected onto it,
making their interpretations subject to caution. To solve this issue,
we introduced population property values for describing the
behavior of cell populations. These values and their statistics,
notably means, standard deviations, and percentage of satisfaction,
offer a more accurate view than phase diagrams. Indeed, even if
we found that the rapid picture offered by STL diagrams are often
consistent with population property values, a few cases illustrated
the need to compute these statistics as well (e.g. T47D cells
manifesting in silico a clear mixed-type behavior with respect to
Property 1, that is not present in the phase diagram in Figure 3).
In addition to computing diagram and population statistics,
STL properties also enable model revision based on experimental
observations. Observed properties are encoded in STL and the
continuous semantics of STL is used to search for valid parameter
values. Traditional model revision methods based on curve fitting
could not be adapted here by lack of well-defined time series data.
The non-standard use of continuous semantics for temporal logic
formula interpretation is essential to allow for an effective search
[46–48]. Using global optimization methods, we found that the
few discrepancies we had identified in earlier steps can be resolved
by modifying only a restricted set of model parameters.
Remarkably, one of the two selected parameters is regulating the
strength of the caspases feedback loop, a process that is predicted
to play an important role in the genesis of type I or type II
behaviors.
The development of experimental methods to probe quantita-
tively subtle aspects of the dynamics of biological processes has
spurred the development of large and complex quantitative models
[49,50]. However the available experimental data is seldom in the
form of time series data directly usable by standard model
validation and model calibration techniques. Therefore tools
allowing for the exploration of model properties, the comparison
between predictions and observations and the revision of models
that are adapted to the available experimental data are
increasingly needed. Temporal logics offer a flexible means to
encode for a broad range of experimentally-observed properties.
Moreover they are also formal languages that allow automating
model analysis. Because it supports STL and uses by default
distributions for parameter and initial concentrations, Breach
naturally allows the exploration of properties of cell populations.
We expect that Breach will become a valuable tool for the
computational biologists to explore model properties, and more
importantly, to get tight connections between experimental data
and model predictions [51].
Methods
Modeling extrinsic apoptosis and cell line differences
We used the model of extrinsic apoptosis proposed by
Aldridge and colleagues [6] named EARM1.4. This model is
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an extension and adaptation of a previous model, EARM1.0,
proposed in [15]. EARM1.0 has been calibrated on HeLa cells
using live and fixed cell imaging, flow cytometry of caspases
substrates and biochemical analysis. EARM1.4 has been
adapted to HCT116, SKW6.4 and T47D cells, and has been
shown to capture their capacity to die or survive in OE-Bcl2
clonogenic experiments. It is a mass-action ODE model based
on nearly 70 reactions and involving 17 native proteins, 40
modified proteins or protein complexes, and TRAIL. For each
cell line, the model assumes different nominal initial protein
concentrations. Nominal concentrations refer here to concen-
trations found in a hypothetical mean cell within the cell
population. More precisely, out of the 17 native proteins, 12
have been quantified by immunoblotting and the relative
differences between cell lines have been used to set nominal
initial protein concentrations for HCT116, SKW6.4 and T47D
cells (see Table 1). Besides initial concentrations, the 3 models
are identical. DXIAP and OE-Bcl2 mutant cell lines are defined
with respect to their parent cell line. In DXIAP cells, the XIAP
concentration is set to 0. In OE-Bcl2 cells, the initial Bcl2
concentration is 10 times higher than in the parent cell line. For
cells with modified feedback (DFB cells) we set the cleavage rate
of caspase 8 by caspase 6, k7, to 0. To represent cell-to-cell
variability within cell lines, we assumed that protein concentra-
tions are log-normally distributed. The means of protein
concentrations were the nominal values. The coefficient of
variation were either measured, for caspase-3 and XIAP [6], or
assumed to be 25% as in [16]. The complete model together
with Breach is available in Supplementary Materials as
MATLAB files (S9). The names of the variables, constants
and reactions used in the model are the same as in [6].
STL semantics and property evaluation
STL is an intuitive yet formal language for specifying the
properties of continuous dynamical systems. It allows us to
express in a (pseudo-) natural language hypothesis on the
mechanistic functioning of the system taken from available
biological knowledge in a formal way so that model consistency
can be precisely and systematically tested. Given a model of the
system, expected properties are expressed using predicates
describing constraints on protein concentrations, like
cPARP,105, traditional logical operators, like and, or and implies,
and temporal operators, like eventually[a,b], always[a,b], and until[a,b].
Time intervals [a,b] limit the scope of temporal operators. These
operators can be combined to create properties of arbitrary
complexities. For example, always[0–6h] (XIAP.10
3 and
cPARP,105) is a valid STL formula. The formal syntax is given
in Table S2 (top). STL properties are then interpreted with
respect to so-called signals. In this context, signals are functions
from time to the reals representing the evolution of the different
concentrations in the system. Computationaly speaking, they
often come from (discrete) time-series data obtained by numerical
simulation of the ODE model. The semantics is defined such that
it captures a notion of distance from satisfaction. For example,
the interpretation at time t of the predicate XIAP.103 is simply
the value of XIAP(t) - 103. Trivially it is positive if XIAP.103, and
negative if XIAP,103. The interpretation of XIAP.103 and
cPARP,105 at time t is the minimum of the value of the two
operands at time t. Note that it is positive if and only if both
operands have positive values. Similarly, the interpretation of
always(XIAP.103) is the minimum of the value of XIAP.103 at
all future time instants. It is positive if XIAP is always greater than
103. The interpretation of STL formulas is also illustrated on
Figure 9. More generally, the continuous interpretation of STL
properties ensures that if the value of a property is positive (resp.
negative), then the property holds (resp. is violated) in a more
usual Boolean interpretation. Moreover, it captures a notion of
‘‘distance from satisfaction’’: a large positive value indicates a
robustly satisfied property, whereas a large negative value
indicates a property that is far from satisfaction. The semantics
is formally defined in Table S2 (bottom). Note that property
values are relative to the formula, in the sense that values
obtained for different STL formulas are not directly comparable
between each other.
Computation of property diagrams
Given an STL property, the associated STL phase diagram is a
representation of the value of the property as a function of the
system’s initial configuration. More precisely diagrams represent
property values in 2D slices of a high dimensional state space.
Each point in the diagram is associated to the value of the STL
formula evaluated on the system’s trajectory starting at this point.
Boundaries were set so as to enclose the variability observed
between cell lines. Diagrams are defined with respect to a
particular cell line: with the exception of the two variables of the
diagram, all other variables assume their nominal values for the
given cell line. Other cell lines are placed on the diagram based on
the initial concentrations of the selected proteins. Unless
mentioned otherwise, the HCT116 cell line is used as a reference.
In practice, a 50650 grid of linearly-spaced points is used for the
computation of each diagram. For each point on the grid, we
computed the cell behavior predicted by the model and then the
value of the STL property associated with this behavior (see
Program S1). The ranges for caspase-3, XIAP, caspase-8 and FLIP
are [0, 106], [0, 6*104], [1200, 4500] and [0, 800], respectively.
Similarly, DLE diagrams represent the direct finite-time Lyapunov
exponent for all points in (a 2D slice of) the state space. This value
captures the sensitivity to initial conditions: DLE(t,x0)~
log lmax((
Lx(t)
Lx0
)T (
Lx(t)
Lx0
)), where lmax(M) denotes the maximum
eigenvalue of the matrixM and t is some future time instant (here 6
or 4 hours). Again, a 50650 grid of linearly-spaced points is used
for the computation of DLE diagrams.
Table 1. Initial concentrations of proteins in HCT116, SKW6.4,
and T47D cells.
Protein\Cell line HCT116 SKW6.4 T47D
FLIP 100 (0.25) 591 (0.25) 48 (0.25)
caspase-8 3500 (0.25) 3255 (0.25) 1680 (0.25)
caspase-6 10000 (0.25) 6700 (0.25) 22500 (0.25)
caspase-3 100000 (0.32) 886000 (0.31) 351000 (0.25)
XIAP 30000 (0.52) 11400 (0.42) 19200 (0.53)
PARP 1000000 (0.25) 1120000 (0.25) 1040000 (0.25)
Bid 40000 (0.25) 74800 (0.25) 53600 (0.25)
Mcl1 1000 (0.25) 1250 (0.25) 4640 (0.25)
Bax 80000 (0.25) 786400 (0.25) 113600 (0.25)
Bcl2 20000 (0.25) 400000 (0.25) 104000 (0.25)
Smac 100000 (0.25) 177000 (0.25) 139000 (0.25)
Nominal values and coefficients of variations for initial protein concentrations
that differ between cell lines (see [6] for concentrations of other proteins).
Protein concentrations are assumed log-normally distributed across the cell
populations.
doi:10.1371/journal.pcbi.1003056.t001
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Computation of STL population data
Given an STL property, the STL population data correspond to
the evaluation of this property on all the simulated individual cell
behaviors among a population of cells of a given cell line. Based on
these property values, statistics are computed. For STL population
data, 5000 different initial conditions are obtained for each cell
line by sampling around its nominal initial conditions from
lognormal distributions. Mean values, value distributions and
percentages of satisfaction of the property (i.e. the percentage of
cells in the population satisfying a given property) are then
computed.
Parameter search procedure
The search procedure has two phases. In the first phase we
search for new parameters for EARM1.4 that lead to full
agreement with experimental data (Figure 7). In the second phase,
when a solution is found, we minimize the number of modified
parameters. We use a cost function composed of three different
components: continuous, Boolean, and parameter penalties. The
continuous penalties correspond to the (negation of) the contin-
uous values of STL properties, and the Boolean penalties
correspond to their Boolean value multiplied by a (negative)
constant. These costs decrease when more properties are
consistent with observations (Bpenalty), and when they are more
robustly consistent with observations (Cpenalty). In the continuous
component, weights are used to balance the importance of all
properties, given their typical range. The last component penalizes
parameter deviations from their original values (Ppenalty). The
overall cost is the weighted sum of these three components.
cost(p) :~aPpenalty(p)zX
i[CellLines
X
p[Properties
(bBpenalty(p,i,p)zcCpenalty(p,i,p))
In the first phase, we selected 43 parameters (14 catalytic rates of
enzymatic reactions and 29 forward rates) out of approximately 80
parameters in EARM1.4. Parameter modifications were limited to
a 100-fold change. We set weights so that the Boolean, continuous,
and parameter penalties contributed to approximately 50%, 30%,
and 20% of the cost, respectively. After 10 hours of computations
(2.2 GHz processor, 8GB RAM), the search converged to a state
in which all expected properties were satisfied by the model (T47D
cells excluded).
In the second phase, we selected the parameters that changed
by more than 5 folds (there were 5 such parameters: kc9, kc25,
kc20, k7 and k24) and run the search again for each pair of these
parameters. The cost function was modified by setting the Cpenalty
parameter to 0, and the beta parameter such as the Boolean
penalty was responsible for approximately 90% of the cost. As a
result, parameter deviations were minimized while preserving the
agreement with the experimental data. We found that reparame-
trization of only one pair of parameters allowed for satisfaction of
all properties for all cell lines.
Breach tool
All the computations have been made using Breach [33,48].
This MATLAB/C++ toolbox allows for efficient numerical
simulation, for sensitivity computation, and for STL property
and DLE evaluation. In particular, DLEs can efficiently be
computed via forward sensitivity analysis [52]. Breach is partic-
ularly oriented towards the analysis of parametric systems, in the
sense that it offers efficient routines for global sensitivity analysis
and parameter search, and that the graphical user interface
facilitates the modification of parameters and initial conditions,
and the exploration of parameter spaces.
Supporting Information
Figure S1 Formula robustness. Number of matches between
predicted and observed satisfaction values for Properties 1–3 in all
HCT116 and SKW6.4 cell lines (Figure 7) as a function of the PARP-
related threshold, a, defining the alive property, of the Apaf-related
threshold, b, defining the MOMP occurrence and of the caspase-
related threshold, c, defining caspases activation when (A) a and b
vary, and c is fixed, or (B) c varies, and a and b are fixed. Thresholds
a, b, and c are defined as follows: p1: = always[0–6h](cPARP/PARPtotal,a);
p2: = eventually(Casp8active and always[0–1h] not Casp3active); p3: =Apaffree/
Apaftotal,b release (cPARP/PARPtotal,a)), where Casp8active: =Casp8*/
Casp8total.c and Casp3active: =Casp3*/Casp3total.c. Full consistency
Figure 9. Evaluation of STL properties. Temporal evolution of the ratio cPARP/PARPtotal, of the value of the property alive: = cPARP/PARPtotal,0.5,
and of Property 1: = always[0–6h]( cPARP/PARPtotal,0.5) for HCT116 and OE-Bcl2 HCT116 cells (left), and SKW6.4 and OE-Bcl2 SKW6.4 cells (right). When
the concentration of cleaved PARP increases, the value of the alive property gradually decreases from a positive value (‘‘true’’) to a negative value
(‘‘false’’). Property 1 at time t evaluates to the minimal value of alive at all future times. So, Property 1 simply captures whether at all times alive holds.
doi:10.1371/journal.pcbi.1003056.g009
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with all experimental data corresponds to 16 matches (15 in Figure 7
and, additionally, p2(SKW6.4)=True). For original properties
(a=b=50% and c=1%), we found three mismatches (Figure 7).
This number is robust with respect to changes of the PARP-related
threshold, a, and of the Apaf-related threshold, b. It is also robust to
the caspase-related threshold, c, provided that this value remains low
enough (i.e. ,2%).
(TIF)
Figure S2 Comparison between DLE and Property 1
STL diagrams. Diagrams representing the values of the DLE
computed at time T (A,C) and of the STL Property:= always[0-T]
(cPARP/PARPtotal,0.5) (B,D) for T= 6 h (A–B) and T=4 h (C–D).
Strikingly, for the two time instants the separatrix is exactly at the
same position, revealing that DLE and Property 1 capture
precisely the same behavior: the existence of two different possible
outcomes: survival or death. However, in full generality the DLE
simply measures the influence of small changes in initial protein
concentrations on the future state of the system. In fact, this
similarity comes from the snap-action aspect of apoptotic cell death,
captured by the EARM model: cell death is immediately preceded
by a sudden activation of effector caspases (all-or-none behavior)
[15]. Small changes in initial protein concentrations will result in
dramatic differences in protein concentrations at the time of death
and therefore in high DLE values. One should also note that the
interpretation of low DLE values is ambiguous, since low values
are found in regions corresponding to type I (SKW6.4) and to type
II cell types (HCT116).
(TIF)
Figure S3 XIAP/capsase-3 STL diagrams for all prop-
erties and using HCT116, SKW6.4 or T47D as reference
cell line. Diagrams representing the values of the STL properties
p1 (A–C), p2 (D–F) and p3 (G–H) computed using HCT116
(A,D,G), SKW6.4 (B,E,H), or T47D (C,F,I) nominal protein
concentrations. Bcl2 is overexpressed in Property 1 diagrams. In
most cases, for a given property the satisfaction values associated
with each cell type is similar irrespectively of the reference cell line
used to construct the diagram. However, there are exceptions, like
in the case of T47D cell line behavior (H and I). So care must be
taken when interpreting STL diagrams. The same situation holds
with DLE diagrams (not shown).
(TIF)
Figure S4 STL property values across all cell lines for
Properties 1–3 for the EARM1.4. For each property, plots
indicate the nominal cell value (top), the distribution (middle), and
the percentage of satisfaction (bottom) of the property values for
populations of cells of different cell lines. Notations are identical to
those used in Figure 4.
(TIF)
Figure S5 Population statistics for Property 1, 2 and 3,
computed with new parameter values. (see Table S1) This
data should be compared with Figure 4, 5 (right), and 6 (right).
The new parameter values allow resolving the inconsistencies
found for SKW6.4, OEBcl2 SKW6.4 cells for Property 2, and for
DXIAP HCT116 cells for Property 3. T47D cells still do not satisfy
Property 3 as expected. Notations are identical to those used in
Figure 4.
(TIF)
Figure S6 XIAP/Capsase-3 STL diagrams computed
with new parameter values for all properties and using
HCT116 or SKW6.4 as reference cell lines. Diagrams
representing the values of the STL properties p1 (A–B), p2 (C–D)
and p3 (E–F), computed using HCT116 (A,C,E) or SKW6.4
(B,D,F) nominal protein concentrations.
(TIF)
Figure S7 FLIP/Capsase-8 STL diagrams computed
with new parameter values for all properties and using
HCT116 or SKW6.4 as reference cell lines. Diagrams
representing the values of the STL properties p1 (A–B), p2 (C–D)
and p3 (E–F), computed using HCT116 (A,C,E) or SKW6.4
(B,D,F) nominal protein concentrations.
(TIF)
Program S1 Computation of STL diagrams using
Breach [33]. The archive contains the freely-distributed Matlab
tool Breach, an implementation of EARM1.4 in Breach, initial
conditions for each of 12 cell lines used in this article, and example
scripts illustrating how to generate STL phase diagrams.
(ZIP)
Table S1 Valid parameters. List of minimal parameter set
leading to Property1–3 satisfaction for all but T47D cells, together
with their new and original values, and the corresponding fold
change.
(TIF)
Table S2 Syntax and semantics of STL [48]. The syntax of
STL formulas is defined inductively. Here, w, w1, w2 are STL
formulas, m(x) is an equality of type f (x(t))w0, with f a real-valued
function on the state x, and [a,b] is a time interval. The real-valued
semantics r(w,t) of an STL formula Q at time t is interpreted on a
real-valued signal x(t) defined on a time interval [0,Tf], where Tf is
typically the end time of a simulation. One additionally defines
w1 orw2 as not(not w1 and not w2), eventually a,b½  w asTrue until a,b½  w
and always a,b½  w as not eventually a,b½  not w.
(TIF)
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